American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Evidence Based Reviews in Surgery

Evidence Based Reviews in Surgery (EBRS) was developed to teach the critical appraisal skills needed by practicing surgeons and residents to interpret and evaluate the surgical literature. Originally developed by the Canadian Association of General Surgeons (CAGS), the program is now a collaborative effort of CAGS and the American College of Surgeons (ACS).

The EBRS program is free of charge to members of the College and offers continuing medical education credit. To view this program that teaches the analytical skills essential for keeping current and practicing evidence based surgery, log in with your member ID. Because this is a free benefit for ACS members, your user name and password are required to gain access.

ACS Disclosure Policy

In accordance with the Accreditation Criteria from Accreditation Council for Continuing Medical Education (ACCME), the American College of Surgeons requires that all clinical and methodological experts and reviewers for Evidence Based Reviews in Surgery disclose any commercial interest that might cause a conflict of interest. The ACCME defines a ‘commercial interest’ as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients." It does not consider providers of clinical service directly to patients to be commercial interests. The ACCME considers “relevant” financial relationships as financial transactions (in any amount) that may create a conflict of interest and occur within the 12 months preceding the time that the individual is being asked to assume a role controlling content of the educational activity.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias. The physicians are contacted by a designated official of EBRS and the conflicts managed to our satisfaction. Please note that if a disclosure has been reported the learner will be advised of the potential COI at the beginning of the pertinent article or review. 

In addition, it is the responsibility of the individual to disclose if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug of unapproved usage. 

The requirement for disclosure is not intended to imply any impropriety of such relationships, but simply to identify such relationships through full disclosure, and to allow the learners to form their own judgments.